Skip to content

Pulmonx Corporation LUNG Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
Savara logo
SavaraSVRA
LQD
Liquidia CorporationLQDA
United Therapeutics logo
United TherapeuticsUTHR
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
LivaNova logo
LivaNovaLIVN

Other financials

Income statement

See full
Revenue$20.6M-8.7%
Gross profit$16.0M-1.8%
Operating income-$13.0M+11.0%
Net income-$13.7M+5.5%
EPS (diluted)-$0.33+8.3%

Balance sheet

See full
Cash & equivalents$61.0M-2.4%
Total debt$56.3M-1.2%
Total equity$45.8M-41.1%
Total assets$120.0M-20.4%

Cash flow

See full
Operating cash flow-$10.1M+23.6%
CapEx$9.0K-97.0%
Free cash flow-$10.1M+25.3%

Valuation

See full
Market cap$54.91M-47.3%
Enterprise value$50.17M-43.5%
P/S0.6×-0.5×

Profitability

See full
Gross margin75.5%+2.0pp
Operating margin-58.8%-5.8pp
Net margin-60.1%-4.4pp
FCF margin-33.2%-4.4pp

Returns & leverage

See full
Return on equity-86.2%+62.6pp
Debt / equity1.2×+0.5×
Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulmonx Corporation's software and technology licenses, net?
Pulmonx Corporation (LUNG) reported software and technology licenses, net of $1.35M in Q1 2026.
How has Pulmonx Corporation's software and technology licenses, net changed year-over-year?
Pulmonx Corporation's software and technology licenses, net decreased by 14.3% year-over-year, from $1.58M to $1.35M.
What is the long-term trend for Pulmonx Corporation's software and technology licenses, net?
Over 5 years (2020 to 2025), Pulmonx Corporation's software and technology licenses, net has grown at a 21.5% compound annual growth rate (CAGR), from $536K to $1.42M.